New York Medical College ( Site 1023) — Valhalla, New York

New York Medical College ( Site 1023) is a clinical research site located in Valhalla, New York, United States 10595.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

New York Medical College ( Site 1023) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Burkitt Lymphoma.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Medical College ( Site 1023)?

New York Medical College ( Site 1023) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Medical College ( Site 1023) conducted?

New York Medical College ( Site 1023) has 1 clinical trials on record, with 1 currently active. Their work covers B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma, Burkitt Lymphoma.

Is New York Medical College ( Site 1023) accredited by Crixeo Health?

New York Medical College ( Site 1023) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Medical College ( Site 1023)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.